Etamycin as a Novel <i>Mycobacterium abscessus</i> Inhibitor
The increase in drug-resistant <i>Mycobacterium abscessus</i>, which has become resistant to existing standard-of-care agents, is a major concern, and new antibacterial agents are strongly needed. In this study, we introduced etamycin that showed an excellent activity against <i>M....
Main Authors: | Bui Thi Bich Hanh, Tae Ho Kim, June-Woo Park, Da-Gyum Lee, Jae-Sung Kim, Young Eun Du, Chul-Su Yang, Dong-Chan Oh, Jichan Jang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/18/6908 |
Similar Items
-
A Screening of the MMV Pandemic Response Box Reveals Epetraborole as a New Potent Inhibitor against <i>Mycobacterium abscessus</i>
by: Taeho Kim, et al.
Published: (2021-05-01) -
Current Molecular Therapeutic Agents and Drug Candidates for Mycobacterium abscessus
by: Nguyen Thanh Quang, et al.
Published: (2021-08-01) -
Rifamycin O, An Alternative Anti-<i>Mycobacterium abscessus</i> Agent
by: Bui Thi Bich Hanh, et al.
Published: (2020-03-01) -
<i>Mycobacterium abscessus</i>: Environmental Bacterium Turned Clinical Nightmare
by: Rose C. Lopeman, et al.
Published: (2019-03-01) -
Alternative and Experimental Therapies of <i>Mycobacterium abscessus</i> Infections
by: Michal Meir, et al.
Published: (2020-09-01)